Hadasit spring seminar “Algorithms and AI Tools as Commercial Assets in the Biomedical Domain”: Biohouse, Hadassah Ein kerem
Hadasit spring seminar: Hands-on aspects of AI and Algorithm protection in the Biomedical Domain.
Topics that were discussed include:
- The potential of AI tools developed during research to become a commercial asset
- Patents vs. Know-how
- Case study from Hadassah research group using AI and algorithms
- Real-world experience from digital health companies building an IP strategy in the algorithm field
- Investors’ view on the IP protection of the AI technologies and its influence on the R&D efforts of the researchers and startups
15:00 – 15:30 – Greg Kirsch, US Patent Attorney, Smith, Gambrell & Russell, USA. “Strategies for protecting with patents computer software and AI inventions in the biomedical sciences: separating the myth from the reality”
15:30 – 15:45 – Shai Rosenberg, Head of Service for Computational Medicine, Hadassah Medical Center – “Case study on Digital Medicine and Artificial Intelligence for the treatment of cancer patients”
15:45 – 16:15 – Two case studies by digital health companies on AI protection strategy:
Erez Naaman, CTO and Co-founder at Scopio Labs.
Dror Zur, CEO at Magentiq Eye LTD.
16:15 – 16:30 – Edith Sokol, Founding Partner Patent Attorney atCohn De Vries Stadler and Co. “Value of IP in algorithm-based technologies – the VC perspective”.
View recordings of the event: